Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 535-544
Open Access | Times Cited: 277

Showing 1-25 of 277 citing articles:

Hallmarks of aging: An expanding universe
Carlos López-Otı́n, Marı́a A. Blasco, Linda Partridge, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 243-278
Open Access | Times Cited: 2642
Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 409
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 309
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 297
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 260
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 228
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 196
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 147
The coming decade in precision oncology: six riddles
Adam Wahida, Lars Buschhorn, Stefan Fröhling, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 43-54
Closed Access | Times Cited: 138
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 137
Machine learning and deep learning applications in microbiome research
Ricardo Hernández Medina, Svetlana Kutuzova, K Nielsen, et al.
ISME Communications (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 129
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Serena Porcari, Nicolas Benech, Mireia Vallès-Colomer, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 712-733
Open Access | Times Cited: 110
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 906-916
Open Access | Times Cited: 109
Microbiome-based interventions to modulate gut ecology and the immune system
Thomas C. A. Hitch, Lindsay J. Hall, Sarah Kate Walsh, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1095-1113
Open Access | Times Cited: 101
Machine learning for microbiologists
Francesco Asnicar, Andrew Maltez Thomas, Andrea Passerini, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 191-205
Open Access | Times Cited: 77
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
Lijun Ning, Yilu Zhou, Han Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 67
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 65
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim, Elena Shklovskaya, Jenny Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 53
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 52
Intestinal bacteria and colorectal cancer: etiology and treatment
Michael W. Dougherty, Christian Jobin
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 51
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
Tianqun Lang, Runqi Zhu, Xiao Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma
Hong Wu, Xuefeng Leng, Qianshi Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3131-3144
Open Access | Times Cited: 45
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
Laura A. Bolte, Karla A. Lee, Johannes R. Björk, et al.
JAMA Oncology (2023) Vol. 9, Iss. 5, pp. 705-705
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top